Potential role of cytomegalovirus in risk factor of breast cancer

Research Article 
DOI: 10.18081/2333-5106/016-3/54-60
American Journal of BioMedicine
Page 34-40
Maitham Ghaly Yousif
Received October 04, 2019; Accepted December 19, 2019; Published January 27, 2020

 Maitham Ghaly Yousif, Ph.D.


It has been hypothesized that human cytomegalovirus (CMV) may be associated with many cancers in human. However, the role of CMV infection in breast cancer remains unclear. We aimed to assess whether CMV infection have a role in development of breast cancer. A 120 women presented to breast cancer clinic with breast mass. Full history from each woman was taken, full examination including breast examination and lymph-node. Blood was aspirated from each woman for detection of CMV IgG, IgM, tp53 and CA15-3 by ELISA. A 50 patients were documented to have breast cancer by histopathological examination. The study reveal that was heights level of CMV IgG and IgM among patients with malignant breast mass (12/50) and (8/50) respectively in other side the lowest level in benign tumor (6/50) and (2/50) respectively and high prevalence of CMV in breast cancer. In conclusion There is strong evidence suggest that CMV has an important role in the development of breast cancer.

Keywords: Cytomegalovirus Breast cancer ; Cancer

Copyright © 2016 by The American Society for BioMedicine and BM-Publisher, Inc.

Article citationReferencesFull-Text/PDFFeedback
The citation data is computed by the following citation measuring services:

Google scholarcitedby


1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65(2):87-108. [PubMed]

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65(1):5-29. [PubMed]

3. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490(7418):61-70. [Abstract/Full-text]

4. Aituov B, Duisembekova A, Bulenova A, Alibek K. Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm? Infectious agents and cancer 2012;7(1):18.  [Abstract/Full-text]  

5. Alibek K, Kakpenova A, Baiken Y. Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infectious agents and cancer 2013;8(1):7. [PubMed]

6. Alibek K, Karatayeva N, Bekniyazov I. The role of infectious agents in urogenital cancers. Infectious agents and cancer 2012;7(1):35. [PubMed]

7. Hausen HZ. Viruses in human cancers. Curr. Sci 2001;81:523-527. [Abstract/Full-text]

8. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 2006;118:3030-3044. [Abstract/Full-text]

9. Mohamed HT, Abdel Fattah HH,  El-Shinawi M, et al. Inflammatory breast cancer: Mixed viral infections within carcinoma tissues and the expression of Ki-67 proliferation marker. J Clin Oncol 2015;33(suppl; abstr e22238). [Abstract/Full-text]

10.  Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T. Breast cancer prognostic classification in the molecular era: The role of histological grade. Breast Cancer Res 2010; 12:207. [PubMed]

11. Paya C, Humar A, Dominguez E et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004;4:611-620. [Abstract/Full-text]

12. Gasco M, Shami S, Crook T. The p53 pathway in breast cancer. Breast Cancer Res 2002,4:70-76. [Abstract/Full-text]

13. George P. P53 how crucial is its role in cancer? Int J Curr Pharm Res 2011;3:19­-25. [Abstract/Full-text]

14. Keyhani M, Nasizadeh S, Dehghannejad A. Serum Ca15-3 measurement in breast cancer patients before and after mastectomy. Arch Iranian Med 2005;8(4):263-266. [Abstract/Full-text]

15. Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007 33(3):266-70. [PubMed]

16. Bast RC, Ravdin P, Hayes DF. Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Onc 2001;19(6):1865-78. [PubMed]

17. Gautam A, Verma S, Pantola C, Verma S.  Utility of CA 15-3 as Diagnostic and Prognostic Marker in Breast Cancer. IOSR Journal of Dental and Medical Sciences 2015;14:17-20. [Abstract/Full-text]

18. Arslan N, Serdar M, Deveci S, et al. Use CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis. Annals of nuclear medicine 2000;14:395-399. [PubMed]

19. Richardson AK, Cox B, McCredie MR, et al. Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br J Cancer 2004;90(11):2149-52. [PubMed]

20. Harkins LE, Matlaf LA, Soroceanu L, et al. Detection of human cytomegalovirus in normaland neoplastic breast epithelium. Herpesviridae 2010;1(1):8. [PubMed]

21. Tsai JH1, Tsai CH, et al. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005;75(2):276-81. [PubMed]


limited access

1. Access this article  through your login credentials or your institution

Get Access

2. Access this article through OpenAthens/Sign in

3. Purchase this article at rate $55.00 and received Full-Text/PDF
You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use. Use the coding below to purchase your article as PDF by credit card, debit card, payball will be asked to supply your billing card information. Before continue with your purchase please read carefully the AJBM terms and conditions of purchase.

Purchase Article

For any technique error please contact us and will be response to sending purchase article by email.

Thank you for visiting American Journal of BioMedicine.  * = Required fields

[gravityform id="6" name="Feedback"]